Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OSI Developing Tarceva I.V. Formulation, Expected To Aid In Reimbursement

Jun 16 2003

• By The Pink Sheet

Related Content

Oral Cancer Drug Coverage Bill May Move In Combo With AWP Reform

May 06 2002

Iressa Approval Upholds Standard For Oncology Subpart H Approvals – FDA

May 12 2003

OSI Confident On Tarceva After Iressa Approval; Brain Cancer Is Back-Up Plan

May 19 2003

Erbitux BLA Resubmission Plan Set; Will Test Accelerated Approval Rules

Jun 09 2003

Iressa Activity Not Likely Predicted By EGFR Expression Level – AstraZeneca

Nov 11 2002

Iressa Patients’ Lack Of Rash Suggests Dose Is Too Low For Benefit – OSI

Oct 07 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window